Apoha
London, GB · 7 known investors
Find your way into Apoha
1,939 people in our graph share verified history with the Apoha team — schools, employers, funds. One of them is your warm intro.
Chris Bischoffunlockedknows Anshika Srivastava · together at Goldman Sachs (overlapped)
.jpg)
×11knows the team · via Goldman Sachs
Apoha develops technology that measures a new layer of molecular data governing how biologics behave and how products perform, positioning itself as a data layer for AI. It serves industries that depend on the predictable behavior of matter, with applications including biologics/antibody design and analysis of food systems.
Founders & leadership
AS
Anshika Srivastavain𝕏COO, co-founderCo-founder and COO of Apoha, which develops a molecular science data class used to design medicines, food, and materials for R&D applications in the deeptech and biotech space.
SS
Shamit Shrivastavain𝕏CEO, co-founderBefore co-founding the company in 2021, he spent six years at the University of Oxford as a postdoctoral research assistant and then senior research associate, following postdoctoral and doctoral research at Boston University, where he also taught solid biomechanics. He completed his undergraduate thesis at the Center for Nanotechnology at IIT Guwahati and was a BSF Fellow with Wilbe in 2020.
Investors · 7
Funding
SEC filings, press & company announcements$36M disclosed across 1 of 4 rounds · 2026
- Undisclosed amountSeries AJul 2026Source ↗
- Undisclosed amountOther FundingJun 2026Source ↗
- $36MraisedJun 2026 · 7 sourcesSource ↗
- Undisclosed amountSeries AJun 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- APOHA LIMITED
- Company number
- 13344316
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 19 Apr 2021
- Registered office
- Nw Works Units 8 & 9, 135 Salusbury Rd, London, NW6 6RJ
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 30 Apr 2025 · next due 30 Sept 2026
- Confirmation statement
- last made up to 11 Apr 2026 · next due 25 Apr 2027
Current officers · 4
- Raffi Kamber — director, appointed 25 Mar 2026
- Shamit Shrivastava — director, appointed 19 Apr 2021
- Michael Sidler — director, appointed 3 Oct 2023
- Anshika Srivastava — director, appointed 11 May 2021
Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Apoha do?
- Apoha develops technology that measures a new layer of molecular data governing how biologics behave and how products perform, positioning itself as a data layer for AI. It serves industries that depend on the predictable behavior of matter, with applications including biologics/antibody design and analysis of food systems.
- Who founded Apoha?
- Apoha was founded by Anshika Srivastava, Shamit Shrivastava.
- Who are Apoha's investors?
- Apoha's investors include Acequia Capital (AceCap), Seedcamp, Draper Associates, Nucleus Capital, R7 Partners, redalpine, Singular.
- How much funding has Apoha raised?
- Apoha has disclosed $36M raised across 1 of its 4 known rounds.
- Where is Apoha headquartered?
- Apoha is headquartered in London, GB.